Hayashi Y, Rabin B C, Guo T Z, Maze M
Department of Anesthesia, Stanford University, California, USA.
Anesthesiology. 1995 Oct;83(4):816-22. doi: 10.1097/00000542-199510000-00022.
alpha 2 Adrenoceptors are coupled to G-proteins sensitive to pertussis toxin (PTX) in the locus coeruleus. At this site, the hypnotic response to dexmedetomidine, an alpha 2 agonist, can be blocked by pretreatment with PTX. G-proteins sensitive to PTX may also be involved in the transduction of anesthetic and analgesic responses to alpha 2 agonists at supraspinal or spinal sites. To address this question the effects of pretreatment with PTX administered intracerebroventricularly, intrathecally, or a combination of the two were examined on the MAC for halothane, and the anesthetic-sparing and analgesic effects of a systemically administered alpha 2 agonist, dexmedetomidine.
Rats were cannulated intracerebroventricularly, intrathecally, and with a combination of intracerebroventricular/intrathecal and treated with PTX (0 and 2.5 micrograms intracerebroventricularly; 0 or 0.5 microgram intrathecally; 0 + 0 or 2.5 + 0.5 intracerebroventricular-intrathecal)). After 7 days, either the analgesic (tail-flick latency) or the MAC-sparing effects of a calculated 50% effective dose of dexmedetomidine were measured. To confirm that intracerebroventricularly administered PTX was effective, ribosylation of G-proteins was assessed in periventricular brain tissue.
The analgesic action of dexmedetomidine was blocked by PTX intrathecally but not by PTX via the intracerebroventricular route. The MAC-sparing action of dexmedetomidine was not blocked by PTX via the intrathecal or intracerebroventricular routes alone or in combination. Yet, intracerebroventricularly administered PTX effectively ribosylated the G-proteins.
Taken together with the authors' previous report, these data suggest that the hypnotic and the analgesic responses to dexmedetomidine are transduced via PTX-sensitive G-protein-coupled alpha 2 adrenoceptors but at separate sites (analgesic-spinal; hypnotic-locus coeruleus). Further studies are needed to localize the precise site(s) for the MAC-sparing effect of dexmedetomidine and to establish whether PTX-sensitive G-proteins are involved in this response.
α2肾上腺素能受体与蓝斑中对百日咳毒素(PTX)敏感的G蛋白偶联。在此部位,α2激动剂右美托咪定的催眠反应可被PTX预处理阻断。对PTX敏感的G蛋白也可能参与了α2激动剂在脊髓上或脊髓部位的麻醉和镇痛反应的转导。为解决这个问题,研究了经脑室内、鞘内或两者联合给予PTX预处理对氟烷最低肺泡有效浓度(MAC)的影响,以及系统给予α2激动剂右美托咪定的麻醉增效和镇痛作用。
将大鼠进行脑室内、鞘内插管,并采用脑室内/鞘内联合插管,用PTX(脑室内0和2.5微克;鞘内0或0.5微克;脑室内-鞘内0 + 0或2.5 + 0.5)进行处理。7天后,测量计算出的50%有效剂量右美托咪定的镇痛(甩尾潜伏期)或MAC增效作用。为证实脑室内给予的PTX有效,评估脑室周围脑组织中G蛋白的核糖基化。
鞘内给予PTX可阻断右美托咪定的镇痛作用,但经脑室内途径给予PTX则不能。右美托咪定的MAC增效作用单独或联合经鞘内或脑室内途径给予PTX均未被阻断。然而,脑室内给予的PTX能有效地使G蛋白核糖基化。
结合作者之前的报告,这些数据表明,对右美托咪定的催眠和镇痛反应是通过对PTX敏感的G蛋白偶联α2肾上腺素能受体转导的,但在不同部位(镇痛-脊髓;催眠-蓝斑)。需要进一步研究来确定右美托咪定MAC增效作用的确切部位,并确定对PTX敏感的G蛋白是否参与此反应。